EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)

CompletedOBSERVATIONAL
Enrollment

136

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Acute Hepatic Porphyria
Trial Locations (30)

10029

Clinical Trial Site, New York

19107

Clinical Trial Site, Philadelphia

27157

Clinical Trial Site, Winston-Salem

33136

Clinical Trial Site, Miami

48109

Clinical Trial Site, Ann Arbor

77555

Clinical Trial Site, Galveston

84112

Clinical Trial Site, Salt Lake City

94143

Clinical Trial Site, San Francisco

Unknown

Clinical Trial Site, Camperdown

Clinical Trial Site, Leuven

Clinical Trial Site, Sofia

Clinical Trial Site, Prague

Clinical Trial Site, Helsinki

Clinical Trial Site, Paris

Clinical Trial Site, Chemnitz

Clinical Trial Site, Petah Tikva

Clinical Trial Site, Milan

Clinical Trial Site, Modena

Clinical Trial Site, Mexico City

Clinical Trial Site, Rotterdam

Clinical Trial Site, Bergen

Clinical Trial Site, Warsaw

Clinical Trial Site, Cape Town

Clinical Trial Site, Seoul

Clinical Trial Site, Barcelona

Clinical Trial Site, Murcia

Clinical Trial Site, Zurich

Clinical Trial Site, Taipei

Clinical Trial Site, Cardiff

Clinical Trial Site, London

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY